Status:

COMPLETED

Study of 2 Modalities of Dialysis and Nutrition on the Nutritional Status of Malnourished Chronic Renal Disease Patients

Lead Sponsor:

GCS Ramsay Santé pour l'Enseignement et la Recherche

Conditions:

Renal Insufficiency

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Describe the impact of dialysis by high permeability and adsorbent membrane (PEPA®) associated with oral nutritional supplementation on the nutritional status of malnourished chronic end-stage renal d...

Detailed Description

The study proposes to compare the nutritional state after 6 months of dialysis with standard membrane associated with intradialytic parenteral nutrition (retrospective phase) with the nutritional stat...

Eligibility Criteria

Inclusion

  • Patient with renal failure, on hemodialysis for at least 12 months;
  • Hemodialysis patient in 3 weekly sessions on a device with a standard permeability membrane (polysulfone, polyethersulfone or polyartylethersulfone type);
  • Malnourished patient, on intradialytic parenteral nutrition for at least 6 months;
  • Patient who may benefit, according to the doctor, from a change in dialysis and nutrition strategy:
  • Patient who signed an informed consent form to participate in the study

Exclusion

  • Known allergy to PEPA® ;
  • Protected patient (under legal protection, or deprived of liberty by judicial or administrative decision);
  • Patient with a chronic infection in progress;
  • Patient with life expectancy \<6 months according to the investigator;
  • Inability to understand information related to the study (linguistic, psychological, cognitive reason, etc.);
  • Pregnant woman or likely to be (of childbearing age, without effective contraception) or breastfeeding;
  • Patient participating in another clinical trial, or in a period of exclusion from another clinical trial;
  • Patient not benefiting from a social security scheme.

Key Trial Info

Start Date :

July 21 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 4 2021

Estimated Enrollment :

11 Patients enrolled

Trial Details

Trial ID

NCT04445558

Start Date

July 21 2020

End Date

June 4 2021

Last Update

January 5 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hôpital Privé La Louvière

Lille, France